Kala Pharmaceuticals, Inc. (KALA)

NASDAQ: KALA · IEX Real-Time Price · USD

6.76

-0.07 (-1.02%)

At close: Jul 19, 2024, 4:00 PM

7.05

+0.29 (4.29%)

Pre-market: Jul 22, 2024, 7:05 AM EDT

Kala Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-39.55	-42.2	-44.82	-142.61	-104.33	-94.35	Upgrade
Depreciation & Amortization	0.53	0.47	0.98	2.31	2.84	2.62	Upgrade
Share-Based Compensation	8.52	7.46	7.01	16.09	13.31	9.99	Upgrade
Other Operating Activities	1.42	6.34	-42.07	15.97	-2.52	-10.98	Upgrade
Operating Cash Flow	-29.09	-27.93	-78.91	-108.24	-90.69	-92.72	Upgrade
Capital Expenditures	-0.47	-0.56	-0.2	-0.79	-1.94	-1.34	Upgrade
Acquisitions	0	0	62.91	-4.65	0	0	Upgrade
Change in Investments	0.13	0.13	0.01	76.25	-76.27	0	Upgrade
Investing Cash Flow	-0.33	-0.43	62.72	70.8	-78.21	-1.34	Upgrade
Share Issuance / Repurchase	3.7	18.58	32.1	42.82	160.66	9.01	Upgrade
Debt Issued / Paid	0	-10	-40.04	-0.26	-0.03	-0.03	Upgrade
Other Financing Activities	10.38	-0.08	-	-	-	-	Upgrade
Financing Cash Flow	14.09	8.51	-7.94	42.55	160.63	8.98	Upgrade
Net Cash Flow	-15.33	-19.85	-24.13	5.12	-8.28	-85.07	Upgrade
Free Cash Flow	-29.56	-28.49	-79.11	-109.03	-92.64	-94.06	Upgrade
Free Cash Flow Margin	-	-	-2032.55%	-970.01%	-1456.08%	-1548.49%	Upgrade
Free Cash Flow Per Share	-10.51	-11.71	-52.02	-82.82	-88.43	-137.47	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).